Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
624.00
-14.00 (-2.19%)
At close: Mar 6, 2026

Oxford Biomedica Market Cap

Oxford Biomedica has a market cap or net worth of 754.25 million as of March 6, 2026. Its market cap has increased by 112.46% in one year.

Market Cap
754.25M
Enterprise Value
805.80M
Revenue
151.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
624.00

Market Cap Chart

Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 754.25M, an increase of 4,236.34%. That is a compound annual growth rate of 14.16%.

History

DateMarket Cap% Change
Mar 6, 2026754.25M1.42%
Dec 31, 2025743.72M67.15%
Dec 31, 2024444.94M108.92%
Dec 29, 2023212.97M-50.00%
Dec 30, 2022425.96M-59.79%
Dec 31, 20211.06B24.98%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Oxford Nanopore Technologies 1.20B
Genus 1.83B
PureTech Health 303.71M
Avacta Group 299.62M
Scancell Holdings 129.98M
4basebio 83.58M
Bioventix 78.37M
Faron Pharmaceuticals Oy 67.15M
Market Cap Rankings